China Medicine Corporation said a delay in a provincial bidding system caused its Q3 revenues to fall 17% to $10.5 million. Even though margins rose slightly, the increases were not enough to offset Q3’s lower revenues. As a result, net income dipped 10% to $2 million or 13 cents per share. More details...

Stock Symbol: (OTCBB: CHME)